MLSS MILESTONE SCIENTIFIC INC. NYSE · United States

MILESTONE SCIENTIFIC INC. (MLSS) news

MILESTONE SCIENTIFIC INC. is a public biotech or pharmaceutical company listed on NYSE under the ticker MLSS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest MILESTONE SCIENTIFIC INC. news

We have not published a story on MILESTONE SCIENTIFIC INC. yet. When there is news, it will appear here.

MILESTONE SCIENTIFIC INC. annual financials

Line	FY2025	FY2024
Research and development	$449,469	$858,767
Net income (loss)	-$5.7 million	-$4.7 million
Cash from operations	-$2.9 million	-$2.9 million
Cash and equivalents	$1.1 million	$3.3 million
Short-term investments		$0

Latest balance sheet, Mar 31, 2026 (10-Q): cash and equivalents $1.2 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about MILESTONE SCIENTIFIC INC.

What is the ticker symbol of MILESTONE SCIENTIFIC INC.?

MILESTONE SCIENTIFIC INC. trades under the ticker MLSS on NYSE.

Where is MILESTONE SCIENTIFIC INC. listed?

MILESTONE SCIENTIFIC INC. is listed on NYSE.

Which country or territory is MILESTONE SCIENTIFIC INC. listed under?

Our directory records MILESTONE SCIENTIFIC INC. under United States.

Does aibio.space cover MILESTONE SCIENTIFIC INC.?

aibio.space lists MILESTONE SCIENTIFIC INC. among 2,820 public biotech companies and publishes its news here as stories appear.

Is MILESTONE SCIENTIFIC INC. profitable?

MILESTONE SCIENTIFIC INC. reported a net loss of $5.7 million for the fiscal year ended Dec 31, 2025, and used $2.9 million of cash in operations, per its annual report to the SEC.

How much does MILESTONE SCIENTIFIC INC. spend on research and development?

$449,469 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does MILESTONE SCIENTIFIC INC. have?

$1.2 million in cash at Mar 31, 2026, per its 10-Q.

Investor discussion: MILESTONE SCIENTIFIC INC.

Members talk about MILESTONE SCIENTIFIC INC. (MLSS). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at MILESTONE SCIENTIFIC INC., newest first. Each line links the filing it comes from.

May 6, 2026Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:MLSS on TradingView.

Listing details

Company: MILESTONE SCIENTIFIC INC.
Ticker: MLSS
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction